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Abstract
Radiation-associated breast angiosarcoma is a rare diagnosis but is commonly reported. Angiosarcoma occurring in non-
breast tissue in breasts that have been reconstructed with autologous tissue following mastectomy is extremely rare. In
our unit, we have managed two patients with angiosarcoma arising in non-breast tissue autologous reconstructions. Our
report emphasises that any tissue treated with radiotherapy—that is, the residual mastectomy skin flaps or non-breast
tissue autologous reconstructions—are at a risk of secondary angiosarcoma. We also discuss recommended surgical
management, surveillance and genetic testing.
Level of Evidence is V, risk study.
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Radiation-associated breast angiosarcoma is a rare diagnosis but
is commonly reported. Angiosarcoma occurring in non-breast
tissue in breasts that have been reconstructed with autologous
tissue following mastectomy is extremely rare. Thus far only
one case has been reported in the literature [1]. In our unit, we
have managed two patients with angiosarcoma arising in non-
breast tissue autologous reconstructions. Our report emphasises
that angiosarcoma can arise in breasts that have been treated with
mastectomy—in residual skin flaps and in the tissue from the
reconstructions themselves. We also discuss recommended sur-
gical management, surveillance and genetic testing.
Case 1
A 61-year-old patient was diagnosed with bilateral screen-
detected breast cancer and required bilateral mastectomy, ax-
illary node sampling and immediate latissimus dorsi recon-
struction in 2003. Her pathology report suggested a more ad-
vanced tumour on the right (grade 1, oestrogen positive, inva-
sive ductal carcinoma of 22 mm), with one out of seven right
axillary lymph nodes involved; she therefore required adju-
vant radiotherapy (50 Gy in 25 fractions) to her right recon-
structed breast and right supraclavicular fossa.
Five years post-radiotherapy, she developed a ‘bruise’ to the
lower inner quadrant of her right reconstructed breast, over the
mastectomy skin flap (Fig. 1). In addition to the discoloured
area, there was also a small skin nodule which was clinically
suspicious of angiosarcoma. An excision biopsy confirmed the
diagnosis. A neo-mastectomywas warranted and the patient had
chest wall reconstruction using a transposition flap (Fig. 2). This
patient was a poor candidate for free abdominal tissue transfer
since she had multiple abdominal surgeries for ulcerative colitis
and was left with significant rectus diastasis and extensive scar-
ring to her lower abdomen. She also suffered from asthma and
did not favour a microsurgical reconstruction. Her neo-
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mastectomy was curative for angiosarcoma and she required no
further treatment. A year after her chest wall reconstruction, the
patient opted for follow-up locally by the breast surgery team.
To date the patient remains disease free.
Case 2
A 71-year-old patient was diagnosed with multifocal, grade 2,
oestrogen and progesterone positive, invasive ductal carcino-
ma of her left breast in 2007. She underwent left mastectomy,
axillary node clearance (3/13 positive nodes) and immediate
deep inferior epigastric perforator (DIEP) flap reconstruction.
Post-surgery, she required adjuvant chemotherapy, two field
radiotherapy (50 Gy in 25 fractions) to her left reconstruction
and hormonal (anastrozole) therapy. In 2011, she developed a
‘bruise’ to the lower inner quadrant of her left reconstructed
breast. A skin biopsy was taken and suggested benign papil-
lary haemangioma only. The discolouration settled after the
biopsy, and 5 years later (April 2017), she re-presented with a
rash to the lower inner quadrant of her left reconstructed breast
(Fig. 3a). A core biopsy and an excision skin biopsy were
performed, which suggested a vascular process, not typical
of angiosarcoma. After the biopsies, the rash had almost
completely gone and the patient was then kept under close
observation once every 2 months. By November 2017, she
returned with a widespread purple discolouration to the skin
paddle of her DIEP reconstruction that extended onto the low-
er mastectomy skin flap (Fig. 3b). Repeat excision biopsies
suggested the presence of malignant spindle cell proliferation,
which stained positively for CD31 and CD34, confirming the
diagnosis of angiosarcoma. This patient was referred to the
sarcoma multidisciplinary team and she required neo-mastec-
tomy, frozen sections and immediate chest wall reconstruction
with free anterolateral thigh (ALT) flap (Fig. 4). Pathology
confirmed complete excision of high-grade angiosarcoma;
no further treatment was indicated. Since surgery, she has been
kept under regular surveillance by the sarcoma team.
Discussion
Secondary angiosarcoma of the breast, as a result of pre-
vious radiotherapy following breast conservation surgery
or mastectomy, is very rare, with a reported incidence of
0.1–0.2% per year [2]. Although radiation to the breast
was used therapeutically, it can also lead to DNA damage,
resulting in genome instability, which in selected cases
Fig. 2 A transposition flap was required to reconstruct right anterior chest
wall defect, following neo-mastectomy
Fig. 1 Five years post-radiotherapy, patient developed skin
discolouration and a small necrotic skin nodule to the lower inner
quadrant of her right reconstructed breast, over the mastectomy skin flap
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may lead to the formation of sarcoma [2]. It may have a
latency period of several years prior to presentation and
the initial clinical signs can be very subtle, as demonstrat-
ed in our cases. Radiotherapy contributes to a ‘field ef-
fect’ in all previously irradiated tissue; hence, clinical
signs of angiosarcoma can appear on the mastectomy skin
flap or on the skin paddle of the abdominal flap. It is vital
to have a high index of suspicion, close monitoring of the
changes in clinical signs and repeat biopsies as necessary,
in order to diagnose secondary angiosarcoma.
Feinberg et al. recently reviewed the impact of early spe-
cialist management on survival from angiosarcoma and sug-
gested that patients managed initially by the sarcoma team
have fewer local recurrences and significant improved
disease-specific survival [3]. Higher rates of positive margins
have been seen with wide local excision, and specialist sarco-
ma units such as the Royal Marsden suggest radical excision
[4]. Excision of the field change associated with previously
irradiated tissue may lead to better local control, reducing the
incidence of future local recurrence [3]. Our surgical approach
to radiation-associated angiosarcoma is similar to Feinberg
et al.: we advocate radical neo-mastectomy rather than wide
local excision, frozen section for margin analysis and chest
wall reconstruction. Follow-up is in keeping with the
Scottish Sarcoma National Follow-Up guidelines with 4
monthly clinical assessment, chest X-ray and annual regional
imaging [5]. Genetic testing should be considered in this
group of patients, as pre-existing genetic abnormalities such
as BRCA and p53 mutations may potentiate the carcinogenic
effects of irradiation, leading to secondary angiosarcoma
[6–8].
The cases we describe here indicate that angiosarcoma can
occur in breasts that have been treated with mastectomy, and
that breast tissue itself is not a pre-requisite for angiosarcoma
formation. Any tissue treated with radiotherapy—that is, the
residual mastectomy skin flaps or non-breast tissue autolo-
gous reconstructions—are at a risk of secondary
angiosarcoma. It is essential that the treating breast clinician
is aware of this rare but critical possibility.
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Fig. 4 A free anterolateral thigh (ALT) flap was used to reconstruct left
anterior chest wall defect, following neo-mastectomy
Fig. 3 a Ten years post-radiotherapy, patient re-presented with a rash to
the lower inner quadrant of her left reconstructed breast, over the mastec-
tomy skin flap. b Six months following initial biopsy, patient developed a
widespread purple discolouration to the skin paddle of her DIEP recon-
struction that extended onto the lower mastectomy skin flap
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